Skip to main content

2013 to 2021 Saw Decline in Benzodiazepine Initiation Post-AIS

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 17, 2024.

via HealthDay

THURSDAY, Oct. 17, 2024 -- From 2013 to 2021, there was a decline in benzodiazepine initiation for post-acute ischemic stroke (AIS), according to a study published online Oct. 17 in Stroke.

Victor Lomachinsky Torres, M.D., from Massachusetts General Hospital in Boston, and colleagues analyzed a 20 percent sample of U.S. Medicare claims from April 1, 2013, to Sept. 30, 2021, to examine prescription patterns of benzodiazepines at the national level. Beneficiaries aged 65 years or older discharged alive following an AIS who had traditional Medicare coverage and six months of prior enrollment in Parts A, B, and D were included. Data were analyzed for 126,050 beneficiaries (mean age, 78 years).

The researchers found that 4.9 percent of beneficiaries initiated a benzodiazepine within 90 days. Lorazepam and alprazolam were the most prescribed new prescriptions (40 and 33 percent, respectively). Overall, 76 and 55 percent of first fills had a day's supply over seven days and between 15 and 30 days, respectively. Initiation rates were higher for women than men (5.5 and 3.8 percent, respectively). Rates were highest in the Southeast (5.1 percent) and lowest in the Midwest (4.0 percent). From 2013 to 2021, there was a modest nationwide decline in initiation (cumulative incidence difference, 1.6 percent).

"Despite an overall downward trend of benzodiazepine initiation among AIS survivors, we noted a concerning possible overuse pattern of benzodiazepine prescriptions dispensed to patients within 90 days of discharge," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Random Forest AI Model Superior for Inpatient Mortality Prognostication in Cirrhosis

THURSDAY, July 24, 2025 -- For inpatients with cirrhosis, a machine learning (ML) model using random forest (RF) analysis is superior for prediction of inpatient mortality...

Alopecia Areata Associated With Severe Psychosocial Impact

THURSDAY, July 24, 2025 -- Alopecia areata (AA) has a severe psychosocial impact, which is linked to illness perceptions and stigma more strongly than disease severity, according...

Inflammation and Nutrition-Based Scores Tied to Prognosis of Low-Risk Myelodysplastic Syndrome

THURSDAY, July 24, 2025 -- The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer prognosis of low-risk...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.